[Cerebrovascular complications of thrombocytosis].
Cerebrovascular complications of thrombocytosis may be the presenting symptoms of the disease (thrombocythemia or secondary thrombocytosis). In the light of 3 recently studied cases, the clinical, pathogenic and therapeutic aspects are emphasized. Early diagnosis is fundamental if the occurrence of permanent neurologic dysfunction is to be avoided.
D000368:Aged; D001241:Aspirin / Q000627:therapeutic use; D001766:Blindness / Q000209:etiology; D002526:Cerebellar Diseases / Q000209:etiology; D002530:Cerebellopontine Angle; D005158:Facial Paralysis / Q000209:etiology; D005260:Female; D006801:Humans; D008875:Middle Aged; D009759:Nystagmus, Pathologic / Q000209:etiology; D010291:Paresis / Q000209:etiology; D010292:Paresthesia / Q000209:etiology; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013922:Thrombocytosis / Q000150:complications* / Q000188:drug therapy; D014717:Vertigo / Q000209:etiology
D001241:Aspirin; D013442:Sulfinpyrazone
Les complications cérébro-vasculaires des thrombocytoses.